Results 161 to 170 of about 8,266 (211)

Minoxidil: a comprehensive review

open access: yesJournal of Dermatological Treatment, 2022
Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women. Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/β-catenin ...

exaly   +2 more sources

Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability [PDF]

open access: yesJournal of Cosmetic Dermatology, 2020
BACKGROUND: Topical minoxidil is the only US FDA-approved drug for the treatment of female pattern hair loss (FPHL). While the safety profile of topical minoxidil is excellent, the efficacy of minoxidil in hair growth is extremely low. A recent survey of
Maja Kovačević   +2 more
exaly   +2 more sources

SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth

open access: yesJournal of Cosmetic Dermatology, 2022
BACKGROUND: Minoxidil is a widely used over-the-counter topical treatment for hair loss. The response rate for topical minoxidil is relatively low. Minoxidil is a pro-drug, converted to its active form, minoxidil sulfate, by SULT1A1 enzymes located in ...
Maja Kovačević   +2 more
exaly   +2 more sources

Minoxidil

Annals of Internal Medicine, 1981
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire   +2 more sources

Minoxidil Overdose

Chest, 1993
A 52-year-old man ingested 60 ml of 2 percent topical minoxidil solution resulting in severe hypotension and tachycardia. He was resuscitated with intravenously administered crystalloid solution and treated with intravenously administered dopamine, resulting in a partial hemodynamic improvement.
A R, MacMillan   +2 more
openaire   +2 more sources

Polymyalgia and Minoxidil

Annals of Internal Medicine, 1990
Excerpt To the Editors:Topical minoxidil has been commercially available since 1987 for the treatment of baldness. Except for contact dermatitis, it is considered free of adverse reactions (1).
R, Colamarino, J J, Dubost, B, Sauvezie
openaire   +2 more sources

Minoxidil

Dermatologic Clinics, 1987
Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in ...
openaire   +3 more sources

Evaluation of Minoxidil

American Journal of Health-System Pharmacy, 1980
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex ...
D D, Miller, D W, Love
openaire   +2 more sources

The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis

open access: yesJournal of Clinical Medicine
Background/Objectives: Minoxidil, in addition to its vasodilatory effect, has also immunomodulatory properties that may be partially responsible for its efficacy in alopecia areata.
Michal Ordak   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy